91Â鶹ÌìÃÀ

Showcase Your Groundbreaking Research at 91Â鶹ÌìÃÀ Microbe 2026

Whether you're a student, early-career researcher or seasoned scientist, your research has the potential to change the world. By submitting your abstract, you're not just sharing your work—you're joining a global network of microbial science experts eager to provide feedback, engage in discussions and help you take your career to new heights. 

The 91Â鶹ÌìÃÀ Health Meeting is accepting abstract submissions in these categories:   

• Diagnostics and Laboratory Systems.
• Vaccines, Immunology and Prevention. 
• Antimicrobials and Therapeutics.
• Clinical Infectious Disease and Management.
• Public Health, Surveillance and Systems.
• Microbiomes and Ecosystems Health.
• General submission.

The abstract submission portal is now open.
Download your letter of invitation.

Interested in abstract review? and lend your expertise evaluating abstracts to be presented at 91Â鶹ÌìÃÀ Microbe 2026.

The submission portal will be open during the periods below:

• Early abstracts: Nov. 12—Dec. 2, 2 p.m. ET.
• Regular Abstracts: Dec. 3—Jan. 21 2 p.m. ET.

Submission deadlines are firm. Late abstracts will not be accepted.

• Data must be objectively gathered, analyzed and reported; conclusions must be supported by results.
• Abstracts must demonstrate scientific rigor, including transparency in design, methodology, data collection, analysis and interpretation.
• When applicable, include details on sample size, randomization, blinding and replication.

For antimicrobial or small-molecule studies:

• Include producing organism, purification steps, physical/chemical characterization, structures, MICs and ED₅₀ values.
• A chemical structure or literature reference must be provided; abstracts without defined structures should be submitted to the 91Â鶹ÌìÃÀ Mechanism Discovery Meeting.

Review & Selection

Abstracts are evaluated based on:

• Originality: novelty, innovation or advancement of knowledge.
• Scientific merit and importance: relevance and potential impact on the field.
• Research design and analysis: clarity, rigor and appropriateness of methods.
• Conclusions: strength and justification based on data.
• Quality of presentation: clarity, adherence to instructions and language quality.

Use of Artificial Intelligence (AI), Chatbots or Large Language Models (LLMs)  

Authors are required to disclose any use of AI tools (e.g., for language editing, data analysis or content generation). AI or LLMs cannot be credited as authors. All submitted work must be original. The use of AI-generated content is prohibited unless it's reviewed and verified by the authors for accuracy and appropriateness. Content that lacks sufficient human oversight and validation will not be accepted. 

Decisions of the program committee are final. Abstracts submitted under the "Oral or Poster’" presentation preference are not guaranteed an oral presentation assignment. Abstracts not selected for oral presentation will be assigned as posters.

Case Study Submissions Open Soon

91Â鶹ÌìÃÀ Microbe 2026 will also feature case studies presented by participants in the 91Â鶹ÌìÃÀ Health Meeting program. We invite all participants to submit case studies for consideration, with priority given to medical technologists and trainees (for example, students, pathology residents or infectious disease fellows).

Those chosen will receive mentorship from an invited speaker and will present their case study to peers during a 10–15-minute presentation. Please note that the selection decision is final and cannot be appealed. 

All submitted cases must adhere to HIPAA guidelines, including the removal of any identifying information. Submissions that fail to comply will be disqualified. 

Case Study submission will open in late Nov. 

Technical Support

If you have any questions regarding use of the abstract submission site, please contact technical support at 91Â鶹ÌìÃÀ Support.